This director sell-off reinforces my view (expressed elsewhere too) that the reduced director voting power means other s/h's ("us") incl retail s/h's have greater influence in ending zepos in the future. Especially when they are used (almost in their entirety) simply as a form in increased remuneration---not an incentive for future and LT growth. The directors have grossly abused the option of incentivisation which should be curtailed or disallowed in the future and, if ever used again, definitely NOT for free!
- Forums
- ASX - By Stock
- DRO
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-53
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DRO (ASX) to my watchlist
|
|||||
Last
$2.60 |
Change
0.260(11.1%) |
Mkt cap ! $1.982B |
Open | High | Low | Value | Volume |
$2.41 | $2.60 | $2.41 | $48.35M | 19.18M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5505 | $2.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.60 | 98988 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5505 | 2.590 |
7 | 59449 | 2.580 |
5 | 9470 | 2.570 |
6 | 64001 | 2.560 |
15 | 216295 | 2.550 |
Price($) | Vol. | No. |
---|---|---|
2.600 | 98905 | 25 |
2.610 | 39183 | 6 |
2.620 | 121287 | 5 |
2.630 | 9612 | 3 |
2.640 | 1000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
DRO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online